13F filer · CIK 1510481 ↗
Sarasin & Partners LLP
You are looking at Q2 2022. See the latest, Q3 2026 →
Reported value
$7.93B
−20% on the quarter before
Positions
88
5 new · 5 sold out
Top 10
39.6%
of the value
Est. gain
−$1.53B
on stocks held all quarter
Est. return
−17.2%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Sarasin & Partners LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- International Flavors&Fragra~$165.7MAdded · 0.1% → 2.2%+1,390,723 shares
- Cisco~$70.8MAdded · 0.4% → 1.3%+1,660,645 shares
- Thermo Fisher Scientific Inc~$68.3MAdded · 0.8% → 1.8%+125,631 shares
- Walt Disney Company (The)~$44.8MAdded · 3.2% → 3.3%+474,701 shares
- Nextera Energy Inc~$29.7MAdded · 3.5% → 4.4%+382,869 shares
- Edwards Lifesciences Corp~$24.1MNew · 0.0% → 0.3%+253,530 shares
- Medical Pptys Trust Inc~$20.8MAdded · 1.1% → 1.3%+1,363,968 shares
- Prologis~$12.7MAdded · 0.5% → 0.6%+108,132 shares
- First Rep Bk San Francisco C~$11.3MAdded · 1.2% → 1.5%+78,405 shares
- National Instrs Corp~$10.8MAdded · 1.4% → 1.5%+344,391 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Marriott Intl Inc New~$198.6MSold out · 2.0% → 0.0%−1,129,852 shares
- Merck & Co Inc~$103.9MCut · 4.0% → 4.3%−1,139,901 shares
- Jpmorgan Chase & Co~$94.2MCut · 1.3% → 0.2%−836,403 shares
- Colgate Palmolive Co~$58.4MCut · 3.2% → 3.5%−728,439 shares
- Equinix~$57.9MCut · 2.4% → 1.9%−88,087 shares
- Aramark~$43.3MCut · 2.9% → 2.4%−1,413,521 shares
- Owens Corning New~$35.6MSold out · 0.4% → 0.0%−389,001 shares
- Apple~$32.3MCut · 0.6% → 0.2%−236,509 shares
- Henry Jack & Assoc Inc~$31.4MCut · 1.3% → 1.1%−174,629 shares
- Deere & Co~$30.5MCut · 3.3% → 2.6%−101,807 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −4.9% · price −16.7% | 5.6% | $444.6M | −$89.1M | ||||||||
| Nextera Energy IncCOM · shares +9.3% · price −8.6% | 4.4% | $348.8M | −$29.9M | ||||||||
| Merck & Co IncCOM · shares −23% · price +11.1% | 4.3% | $343.2M | +$34.3M | ||||||||
| Cme Group IncCOM · shares +0.6% · price −13.9% | 4.1% | $325.9M | −$52.5M | ||||||||
| Amgen IncCOM · shares −3.3% · price +0.6% | 4.0% | $320.9M | +$2.0M | ||||||||
| MastercardCL A · shares −4.8% · price −11.7% | 3.9% | $308.5M | −$41.0M | ||||||||
| Colgate Palmolive CoCOM · shares −18% · price +5.7% | 3.5% | $273.7M | +$14.7M | ||||||||
| Walt Disney Company (The)COM · shares +20% · price −31.2% | 3.3% | $265.6M | −$100.0M | ||||||||
| Otis Worldwide CorpCOM · shares −2.3% · price −8.2% | 3.2% | $255.9M | −$22.7M | ||||||||
| AmazonCOM · shares −2.2% · price −38.1% | 3.2% | $250.7M | −$154.3M | ||||||||
| AlphabetCAP STK CL C · shares −6.7% · price −21.7% | 2.9% | $233.4M | −$64.6M | ||||||||
| Deere & CoCOM · shares −13% · price −27.9% | 2.6% | $203.7M | −$78.9M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares −2.8% · price −10.4% | 2.4% | $192.5M | −$22.3M | ||||||||
| AramarkCOM · shares −18% · price −18.5% | 2.4% | $191.8M | −$43.6M | ||||||||
| Costco Whsl Corp NewCOM · shares −6.1% · price −16.8% | 2.4% | $190.0M | −$38.3M | ||||||||
| Service Corp IntlCOM · shares −3.7% · price +5.0% | 2.3% | $178.7M | +$8.5M | ||||||||
| International Flavors&FragraCOM · shares +1,464% · price −9.3% | 2.2% | $177.0M | −$1.2M | ||||||||
| TSMCSPONSORED ADS · shares +3.2% · price −21.6% | 2.1% | $168.1M | −$44.8M | ||||||||
| Middleby CorpCOM · shares −8.1% · price −23.5% | 2.1% | $164.7M | −$50.7M | ||||||||
| Splunk IncCOM · shares −6.2% · price −40.5% | 2.0% | $160.5M | −$109.1M | ||||||||
| EquinixCOM · shares −28% · price −11.4% | 1.9% | $151.1M | −$19.5M | ||||||||
| ServiceNowCOM · shares +3.7% · price −14.6% | 1.8% | $144.4M | −$23.8M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +93% · price −8.0% | 1.8% | $141.7M | −$6.4M | ||||||||
| American TowerCOM · shares −8.3% · price +1.7% | 1.6% | $124.8M | +$2.1M | ||||||||
| Illumina IncCOM · shares +7.4% · price −47.2% | 1.5% | $118.0M | −$98.3M | ||||||||
| Total · 88 positions | 100% | $7.93B | −$1.53B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 83 stocks held throughout, down $1.53B (−17.2%).
- Merck & Co Inc+$34.3M+11%
- Colgate Palmolive Co+$14.7M+6%
- Service Corp Intl+$8.5M+5%
- Eli Lilly+$3.2M+13%
- American Tower+$2.1M+2%
- Microsoft−$89.1M−17%
- Illumina Inc−$98.3M−47%
- Walt Disney Company (The)−$100.0M−31%
- Splunk Inc−$109.1M−40%
- Amazon19:1 split−$154.3M−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 13, 2026 | $8.93B+5% | SEC ↗ |
| Q2 2026 | Jul 7, 2026 | $8.54B+4% | SEC ↗ |
| Q1 2026 | Apr 13, 2026 | $8.20B−15% | SEC ↗ |
| Q4 2025 | Jan 8, 2026 | $9.63B−5% | SEC ↗ |
| Q3 2025 | Oct 10, 2025 | $10.19B+1% | SEC ↗ |
| Q2 2025 | Jul 9, 2025 | $10.05B+9% | SEC ↗ |
| Q1 2025 | Apr 15, 2025 (amended) | $9.22B+2% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $9.06B−14% | SEC ↗ |
| Q3 2024 | Oct 9, 2024 | $10.60B−6% | SEC ↗ |
| Q2 2024 | Jul 19, 2024 | $11.29B+11% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $10.16B+12% | SEC ↗ |
| Q4 2023 | Jan 10, 2024 | $9.10B+14% | SEC ↗ |
| Q3 2023 | Oct 5, 2023 | $8.01B−7% | SEC ↗ |
| Q2 2023 | Jul 11, 2023 | $8.62B−54% | SEC ↗ |
| Q1 2023 | Apr 27, 2023 (amended) | $18.57B+143% | SEC ↗ |
| Q4 2022 | Jan 30, 2023 | $7.64B+6% | SEC ↗ |
| Q3 2022 | Oct 18, 2022 | $7.22B−9% | SEC ↗ |
| Q2 2022 | Jul 13, 2022 | $7.93B−20% | SEC ↗ |
| Q1 2022 | Apr 11, 2022 | $9.95B−9% | SEC ↗ |
| Q4 2021 | Jan 19, 2022 | $10.98B+11% | SEC ↗ |
| Q3 2021 | Oct 22, 2021 | $9.91B+3% | SEC ↗ |
| Q2 2021 | Jul 13, 2021 | $9.58B+13% | SEC ↗ |
| Q1 2021 | Apr 29, 2021 | $8.48B+12% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $7.56B+9% | SEC ↗ |
| Q3 2020 | Nov 9, 2020 | $6.91B+11% | SEC ↗ |
| Q2 2020 | Jul 17, 2020 | $6.25B+23% | SEC ↗ |
| Q1 2020 | Apr 30, 2020 | $5.09B−22% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $6.54B+8% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $6.04B+6% | SEC ↗ |
| Q2 2019 | Jul 18, 2019 | $5.72B+10% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $5.19B+13% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $4.60B−13% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $5.31B+4% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $5.09B−0% | SEC ↗ |
| Q1 2018 | May 1, 2018 | $5.11B−1% | SEC ↗ |
| Q4 2017 | Feb 6, 2018 | $5.15B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $4.96B−3% | SEC ↗ |
| Q2 2017 | Aug 3, 2017 | $5.11B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $5.14B−13% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $5.91B−7% | SEC ↗ |
| Q3 2016 | Oct 14, 2016 | $6.38B+6% | SEC ↗ |
| Q2 2016 | Jul 14, 2016 | $6.02B−2% | SEC ↗ |
| Q1 2016 | Apr 27, 2016 | $6.13B | SEC ↗ |